MarkBallowMD

PubMed

• Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replac...
  Mark Ballow, Raúl Ortiz-de-Lejarazu, Isabella Quinti, Matthew S Miller, Klaus Warnatz
  Frontiers in Immunology. 2024-01-01
• Must Reads for Clinicians Seeking a Better Understanding of Primary Immune Deficiency Disorders and Related Disorders.
  Mark Ballow, John B Ziegler
  The Journal of Allergy and Clinical Immunology. in Practice. 2023-06-01
• 4 citations
  Advances and Challenges of the Decade: The Ever-Changing Clinical and Genetic Landscape of Immunodeficiency.
  Jolan E Walter, John B Ziegler, Mark Ballow, Charlotte Cunningham-Rundles
  The Journal of Allergy and Clinical Immunology. in Practice. 2023-01-01

Journal Articles

• Mechanisms of immune regulation by IVIG  
  Ballow, M, Current Opinion in Allergy & Clinical Immunology, 1/1/2014
• Use of vaccines in the evaluation of presumed immunodeficiency  
  Ballow, M, Annals of Allergy, Asthma and Immunology, 1/1/2013
• Newborn screening for SCID in New York State  
  Vogel B, Ballow M, Bonagura V, Celestin J, Cunningham-Rundles C et al, J Clin Immunol, 1/1/2013
• IDF policy statement on exposure of Immunodeficient Children to normal individuals who have not been immunized with standard vaccines or who are carrying live vaccine-...  
  Fleisher TA, Stiehm ER, Shearer T, Ballow M, Buckley RH, Puck J, Gelfand E, Blaese M et al, J Allergy Clin Immunol, 1/1/2013
• Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (BivigamTM IVIG) in patients with primary immunodeficiency  
  Wasserman RL, Church J, Stein M, Moy J, White M, Strausbaugh S, Schroeder H, Ballow M, Harris J, MaIamed I, Elkayam D, Lumry W, Suez D, Rehman RM, J Clin Immunol, 1/1/2012
• Considerations for the Optimal Use of Immunoglobulin (Review)  
  Navarro RP, Ballow M, Fenrick B, Pezalla EJ, The American Journal of Managed Care, 1/1/2012
• Statement regarding "The public health benefits of air pollution control"  
  Ledford DK, Burks, AW, Ballow M, Cox C, Wood RA, Casal TB, Journal of Allergy & Clinical Immunology, 1/1/2012
• Immune response modifiers in the treatment of asthma: A Practall document of the AAAAI and EAACI  
  Ballow M, Akdis CA, Casale TB, Wardlaw AJ, Wenzel SE, Ballas Z, Lotvall J, Journal of Allergy and Clinical Immunology, 1/1/2012
• Maintenance of certification clinical management series-Vaccines in the assessment of patients for immune deficiency  
  Ballow M, Journal of Allergy and Clinical Immunology, 1/1/2012
• Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the Ameri...  
  Orange JS, Ballow M, Stiehm ER, Ballas ZK, Chinen J, de la Morena M et al, J Allergy Clin Immunol, 1/1/2012
• Dosing and therapy utilization: a discussion of updates on PI treatment guidelines  
  Ballow, M, Journal of Clinical Immunology, 1/1/2012
• The patient, the physician, and the payor: a multiperspective look at the challenges of treating primary immunodeficiency  
  Ballow, M, Journal of Clinical Immunology, 1/1/2012
• Efficacy and Safety of a New Immunoglobulin G Product, Gammaplex (R), in Primary Immunodeficiency Diseases  
  Moy J, Sharenberg A, Stein M, Suez D, Roberts R, Levy R, Ballow M, Fasano M, Dash C, Leach S, Clinical and Experimental Immunology, 1/1/2011
• The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders  
  Ballow M, J Allergy Clin Immunology, 1/1/2011
• Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytes  
  Ballow M, Allen C, Clinical Immunology, 1/1/2011
• Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies  
  Yong PL, Boyle J, Ballow M, Boyle M, Berger M, Bleesing J, Bonilla FA, Chinen J, Cunninghamm-Rundles C, Fuleihan R, Nelson, L, Wasserman RL, Williams K, Orange JS, Clinical Immunology, 1/1/2010
• Therapeutic use of immunoglobulins  
  Stiehm ER, Orange JS, Ballow M, Lehman H, Advances in Pediatrics, 1/1/2010
• Efficacy, Pharmacokinetics, Safety and Tolerability of Flebogamma (R) 10% DIF, a High-Purity Human Intravenous Immunoglobulin, In Primary Immunodeficiency  
  Berger M, Pinciaro PJ, Althaus A, Ballow M, Chouksey A, Moy J, Ochs H, Stein M, Journal of Clinical Immunology, 1/1/2010
• Monoclonal antibodies and fusion proteins and their complications: Targeting B cells in autoimmune diseases  
  Lee S, Ballow M, J Allergy Clin Immunology, 1/1/2010
• Atopic Dermatitis  
  Wasserbauer, N. Ballow M, American Journal of Medicine, 1/1/2009
• Depressed children with asthma evidence increased airway resistance: "Vagal bias" as a mechanism?  
  Miller BD, Wood BL, Lim JH, Ballow M, Hsu C, Journal of Allergy and Clinical Immunology, 1/1/2009
• Clinical experience with Flebogamma (R) 5% DIF: a new generation of intravenous immunoglobulins in patients with primary immunodeficiency disease  
  Ballow, M, Clinical & Experimental Immunology, 1/1/2009
• Immunodeficiencies  
  Ballow M, Notarangelo L, Grimbacher B, Cunningham-Rundles C, Stein M, Helbert M, Gathmann B, Kindle G, Knight AK, Ochs HD, Sullivan K, Franco JL, Clinical & Experimental Immunology, 1/1/2009
• Depressed children with asthma evidence increased airway resistance: "vagal bias" as a mechanism?  
  Miller BD, Wood BL, Lim J, Ballow M, Hsu C, J Allergy Clin Immunology, 1/1/2009
• A case of recurrent sterile abscesses following vaccination: delayed hypersensitivity to aluminum  
  Lehman HK, Faden H, Fang Y, Ballow M, J Pediatrics, 1/1/2008
• Join now to see all

Books/Book Chapters

• Stiehm's Immune Deficiencies 
  Chapter: Immune compromise due to metabolic disorders 
  Lehman, H and Ballow, MEditors: KE Sullivan and ER Stiehm.Elsevier2015
• Middleton's Allergy 
  Chapter: Approach to the Patient with Recurrent Infections 
  Page 1133 - 1143Ballow M, Lehman HKEditors: N. Franklin Adkinson Jr, Bochner BS, Burks W, Busse WW, Holgate ST, Lemanske Jr RF, and O'Hehir RE.Elsevier Inc.2014
• Textbook of Clinical Pediatrics 
  Chapter: B-Cell Immunodeficiency 
  Ballow M, Safier BEditors: Elzouki AY.2012
• Goldman's Cecil Medicine 
  Chapter: Primary Immunodeficiency Diseases 
  Ballow, MEditors: Goldman L, and Schafer A.Edition 24th,2011
• Immunology IV: Clinical Applications in Health and Disease 
  Chapter: Advances in Clinical Immunomodulation 
  Nelson Jr., RP and Ballow, MEditors: J.A. Bellanti and H.B. Herscowitz.Plenum, New York, NYEdition 4th,2011
• Clinical Use of Immunoglobulins 
  Chapter: Passive Immunoprophylaxis 
  Page 51 - 60Ballow MEditors: Wahn V, and Orange J.2008
• Clinical Immunology 
  Chapter: Immunoglobulin Therapy: Replacement and Immunomodulation 
  Page 1265 - 1280Ballow, MEditors: Rich RR.Edition 3rd,2008
• Cecil Textbook of Medicine 
  Chapter: Primary Immunodeficiency Diseases 
  Page 1925 - 1934Ballow, MEditors: Goldman L, and Ausiello D.Edition 23rd,2008
• Immunologic Disorders in Infants and Children 
  Chapter: Secondary Immunodeficiencies "Stress-Related Immunodeficiencies: Trauma, Surgery, Anesthesia, Burns, Exercise, and Splenic Deficiencies" 
  Page 952 - 964Ballow MEditors: R. Stiehm, Ochs HD, Winkelstein JA.Edition 5th,2004
• Pediatric Allergy: Principles & Practice 
  Chapter: Intravenous immune serum globulin (IVIG) therapy in patients with antibody immune deficiency 
  Page 183 - 192Ballow MEditors: DYM Leung, HA Sampson, RS Geha, SJ Szefle.Mosby, St. Louis, MO2003
• Clinical Immunology 
  Chapter: Intravenous immunoglobulin in autoimmune and inflammatory diseases 
  Page 104.1 - 104.1Boguniewicz M, and Ballow MEditors: RR Rich.CV Mosby Year Book, St. Louis, MO2001
• Saunders Manual of Pediatric Practice 
  Chapter: Allergy, Immunology, and Pediatric Rheumatology 
  Page 224 - 293Ballow, MEditors: Laurence Finberg.1998
• Clinical Immunology 
  Chapter: Intravenous immune globulin in autoimmune and inflammatory diseases 
  Page 1891 - 1903Boguniewicz M, Kelly CS, Ballow M, and Leung DYMEditors: RR Rich.CV Mosby Year Book, St. Louis, MO1996
• Pediatrics 
  Chapter: Immunology, Allergic and Rheumatic Diseases 
  Ballow, M. , Markowitz, M., and Robinson JEditors: P. Dworkin.Williams & WilkinsEdition 3rd,1995
• Molecular and Cellular Biology of the Allergic Response 
  Chapter: Molecular genetics of immunoglobulin genes and the generation of antibody diversity 
  Ballow M, and Schaffer FEditors: A Levinson and Y Paterson.Marcel Dekker, Inc.1994
• IVIG Therapy Today 
  Ballow M (editor)Editors: Ballow M.Human Press, Totowa, NJ1992
• Allergy: Principles and Practice 
  Chapter: Approach to the patient with recurrent infections 
  Page 1027 - 1058O'Neil K and Ballow MEditors: Middleton, Ellis, Reed, et al.Mosby-Year Book, St. Louis, MOEdition 4th,1992
• Conn's Current Therapy 
  Chapter: Diseases of Allergy: Anaphylaxis and Serum Sickness 
  Page 673 - 676Lantner, R; Ballow, MEditors: R. Rakel.W.B. Saunders Co.1990
• Birth Defect Encyclopedia 
  Chapter: Nezelof Syndrome 
  Page 956 - 957Ballow, MEditors: ML Buyse.Churchill Livingstone, Cambridge, MA1990
• Histamine and H2 Antagonists in Inflammation and Immunodeficiency 
  Chapter: Modulation of Immune Responses by Histamine-2 antagonists in Primary Immune Deficiency Diseases 
  Page 219 - 229Ballow, M; and White, W.B.Editors: R. Rocklin.Marcel Dekker, Inc.1989
• Contact Lenses 
  Chapter: Giant Papillary Conjunctivitis 
  Page 10.1 - 10.18Donshik, P.C.; Luistro, A.; Ballow, MEditors: F. Weinstock.Gower Medical Publishing Limited1987
• Pediatrics 
  Chapter: Immunology, Allergic Disease and Rheumatic Disease 
  Page 165 - 184Ballow, M. and Markowitz, MEditors: P. Dworkin.Harval Publishing Company1987
• Biomedical Foundations of Ophthalmology 
  Chapter: The Immunologic Components of Tears 
  Page 1 - 5Donshik, P.C. and Ballow, MEditors: T. P.Duane.Harper & Row Publishers, Philadelphia, PA1986
• Investigation of Cell-Mediated Immunity, Practical Methods in Clinical Immunology 
  Chapter: In vivo analysis of cell-mediated immunity 
  Ballow, MEditors: T. Yoshida.Churchill Livingstone, Edinburgh, Scotland1985
• Merck Manual 
  Chapter: Host defenses in the newborn 
  Page 287 - 288Cates, L. and Ballow, M1982
• Join now to see all

Abstracts/Posters

• Immunologist' attitudes on "wear-off" effects of IgG replacement therapy for primary immunodeficiency patients.
  Ballow M, Bullinger A, Murphy EA, Berger M, American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, 1/1/2013
• Evaluation of Coverage of Allergy Concepts in Electronic Health Records.
  Yu A, Ballow M, Shvarts A, Lehman H, American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, Journal of Allergy and Clinical Immunology, 1/1/2012
• An Evaluation of Pneumococcal Titers in Patients Receiving Ig Replacement for Immunodeficiency.
  Shvarts A, Ballow M, Yu A, Lehman H, American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, Journal of Allergy and Clinical Immunology, 1/1/2012
• Persistent Atypical Mycobacterium Infection in a Patient with IgA Deficiency and Juvenile Dermatomyositis.
  Yu A, Ballow M, American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, Journal of Allergy and Clinical Immunology, 1/1/2011
• An Infant with Solitary Mastocytoma with Reduction in Frequency of Flares with the Use of Daily Cetirizine.
  Shvarts A, Ballow M, American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting, Annals of Allergy, Asthma & Immunology, 1/1/2011
• Effect of Text Message Medication Reminders on Asthmatic Medication Adherence.
  Lee J, Safier B, Ballow M, American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting, Annals of Allergy, Asthma & Immunology, 1/1/2011
• Impaired Pneumococcal Antibody titers in Children with Down Syndrome.
  Shvarts A, Ballow M, Senn K, Lehman H, American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting, Journal of Allergy and Clinical Immunology, 1/1/2011
• Self-Administration of Asthma Medication in Children and Asthma Control.
  Safier B, Green L, Ballow M, American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting, Journal of Allergy and Clinical Immunology, 1/1/2010
• Effects of IGIV on Dendritic Cell (CD) Maturation and Function.
  Wasserbauer N, Allen C, Ballow M, American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting, Journal of Allergy and Clinical Immunology, 1/1/2009
• Effect of Retinoic Acid on the Expression of the Receptors that Regulate B-cell Homeostasis: TACI, BAFF-R, and BCMA.
  Lieberman A, Allen C, Ballow M, American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting, Journal of Allergy and Clinical Immunology, 1/1/2009
• Zinc Deficiency and Omenn Syndrome.
  Packianathan NB, Lehman HK, Ballow M, American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting, Journal of Allergy and Clinical Immunology, 1/1/2008
• IGIV Effects on Immature Dendritic Cells of Common Variable Immunodeficiency Patients.
  Shah P, Allen C, Ballow M, American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting, Journal of Allergy and Clinical Immunology, 1/1/2008
• Tracheal Pepsin Activity in Intubated Very Low Birth Weight (VLBW) Infants.
  El Abiad, MT, Reynolds AM, Nader N, Yu W, Lakshminrusimha S, Kumar VH, Blessing-Hanagen K, Rich G, Ballow M, Ryan RM, American Thoracic Society- International Conference, San Diego, CA, 1/19/2006
• Case Report: Recurrent pyogenic infections and a possible defect in the signaling pathway for IL-10.
  Shah, P, Puel A, Sheehan D, Ballow M, American College of Allergy, Asthma and Immunology Annual Meeting, Philadelphia, PA, 1/9/2006
• Carimune (R) NF Liquid, a New Ready-to-Use, Liquid Intravenous Immunoglobulin, is Safe and Effective in the Treatment of Primary Immunodeficiency Diseases.
  Ballow M, Cunningham-Rundles C, Bichler J, Bonilla FA, on behalf of the Carimune (R) NF Liquid study group, American College of Allergy, Asthma and Immunology Annual Meeting, Philadelphia, PA, 1/9/2006
• Antibody Deficiency in the New Millennium: Illnesses, Absences and Concomitant Medications - 100 Patient Years Experience.
  Cassidy EA, Pinciaro PJ, Berger M, for the Grifols 04, 04-OLE, IG201 Investigators, American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting, Journal of Allergy and Clinical Immunology, 1/1/2006
• Adenosine Deaminase Deficiency and Storage Pool Deficiency: A Case Report.
  Taylor CS, Petruzzi M, Ballow M, American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting, Journal of Allergy and Clinical Immunology, 1/1/2006
• Initiation of Chronic Anti-Inflammatory Medications in Asthmatic Children in a Pediatric Emergency Department.
  Lehman H, Ballow M, Lillis K, Augustine M, Shaha S, Pediatric Academic Societies' Annual Meeting, Washington, DC, 1/14/2005
• Vitamin A Supplementation in Preterm Infants: Vaccine Response.
  Carrion V, Ballow M, Duffy L, Browne R, Pediatric Academic Societies' Annual Meeting, Washington, DC, 1/14/2005
• The Use of IVIG in an 11 Year Old Male with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS).
  Geller DK, Ballow, M, Annals of Allergy, Asthma & Immunology, 1/1/2005
• Initiation of Chronic Anti-Inflammatory Medications in Children with Asthma in the Pediatric Emergency Department.
  Lehman H, Ballow M, Lillis K, Augustine M and Shaha S, 2004 Pediatric Academic Societies' Annual Meeting, Pediatric Research, 1/1/2004
• Expression and Regulation of Retinoic Acid Nuclear Receptors in Human Lymphoid Cells.
  Ballow M, Wang X, Xiang S, Allen C, Federation of Clinical Immunology Societies (FOCIS) 2nd Annual Meeting, San Francisco, CA, 1/1/2002
• Retinoic Acid Modulates Monocyte/Macrophage-Derived Cytokines from THP-1 and Cord Blood Mononuclear Cells.
  Wang X, Haseeb AQ, Ballow M, Federation of Clinical Immunology Societies (FOCIS) 2nd Annual Meeting, Clinical Immunology, San Francisco, CA, 1/1/2002
• Common Variable Immunodeficiency (CVID) Presenting as Nodular Granulomatous Lung Disease.
  Sands M, Ballow M, American Academy of Allergy, Asthma and Immunology (AAAAI) Conference, Journal of Allergy and Clinical Immunology, 1/1/2002
• Rapid Intravenous (IV) Desensitization for Desferrioxamine (DFO) Hypersensitivity Followed by IV Maintenance Therapy in an Adolescent with Sickle Cell Disease.
  Sands M, Ramesh S, Ballow M, American College of Allergy, Asthma and Immunology (ACAAI) Conference, Annals of Allergy, Asthma & Immunology, 1/1/2002
• Join now to see all

Lectures

• Mechanisms of action of IVIG in autoimmune and inflammatory disease 
  New Orleans, LA - 1/27/2014
• Vaccines as tools for diagnosing primary immunodeficiencies, and IVIG- dosing and management considerations. 
  New Orleans, LA - 1/21/2014
• Evaluation of the Patient with Recurrent Infections 
  Multiple Locations, 2002, 2003, 2004, 2005, 2010, 2014 - 1/20/2014
• Immune response modifiers: the good, bad, and ugly 
  Isle of Palms, SC - 1/20/2014
• New Approaches in IgG dosing for patients with antibody deficiency 
  Isle of Palms, SC - 1/20/2014
• A primer for immunology 
  Orlando, FL - 1/19/2014
• Mechanisms of action of IVIG in Autoimmune Diseases 
  Texas Children's Hospital, 2014; Philadelphia Children's Hospital, 2014 - 1/18/2014
• Candidiasis - A window into Immune Deficiency Diseases 
  Miami Children's Hospital - 1/14/2014
• Antibody replacement therapy 
  Baltimore, MD - 1/29/2013
• Insights into immunological testing 
  Baltimore, MD - 1/28/2013
• Immunodeficiency diseases in Adults 
  1/12/2013
• Treatment guidelines for immune deficiency 
  AK - 1/7/2013
• Immune response modifiers: The good, bad and ugly 
  AK - 1/6/2013
• Practical application of AAAAI guidance on diagnostic vaccines: case studies 
  San Antonio, TX - 1/1/2013
• Therapy for Primary Immune Deficiency Disorders 
  1/29/2012
• New Approaches to IgG Dosing 
  Chicago, IL - 1/17/2012
• Immune response modifiers: Infections and adverse events 
  1/17/2012
• Immunodeficiency: Role of the Allergist 
  Anaheim, CA - 1/12/2012
• Management of Antibody Deficiencies in Older Adults 
  Anaheim, CA - 1/10/2012
• Therapeutic Immunoglobulin: What It Is and How It Works 
  Orlando, FL - 1/5/2012
• When to Use IVIG 
  Orlando, FL - 1/4/2012
• New Uses for Intravenous and Subcutaneous Immunoglobulin Therapy 
  Mineola, NY - 1/21/2011
• Immune Response Modifiers 
  San Francisco, CA - 1/18/2011
• B-Cell Immune Deficiencies 
  Cleveland, OH - 1/8/2011
• Ask an Expert: Rare Diseases That Shouldn't Be Missed 
  Amelia Island, FL - 1/8/2011
• Join now to see all

Other

• Review and Feature Article Primary Immunodeficiency: New Approaches in Genetic Diagnosis, and Constructing Targeted Therapies 
  Mark Ballow, MD, ScienceDirect
  https://www.doximity.com/articles/806fef3a-d305-4f85-a232-c592da14a662
  UpToDate, Wolters Kluwer Health - 2012-06-21
• MKSAP - AI 
  Ballow M and others, American College of Physicians
  Philadelphia, PA - 1/1/1993
• Office Evaluation of Patients with Recurrent Infections. 
  Ballow,M, Current Views in Allergy and Immunology
  1/1/1990
• Opportunistic invaders in immune deficient states: A Study of Pseudomonas and Herpes Viruses. 
  Ballow, M. and Quintiliani, R, SCP Communications
  New York, NY - 1/1/1985
• Clinical Crisis in Immune Deficiency: Mechanisms of Acquired Immunocompromise 
  Ballow, M. and Quintiliani, R.; Maderazo, E., SCP Communications
  New York, NY - 1/1/1984
• Join now to see all